• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Aurobindo Pharma Limited — Board Meeting, 05-08-2026: Outcome of Board Meeting

    05-08-2026 | 07:47 pm

    Aurobindo Pharma reported Q1 consolidated PAT of ₹1,032.03 Cr, revenue of ₹9,150.35 Cr, and EPS of ₹17.86. The board also approved merging Eugia Steriles & SEZ into Eugia Pharma Specialities. These Q1 figures reflect the recent ₹2,334.88 Cr acquisition of Lannett Company LLC.

    No comments yet. Be the first to comment!

    All announcements from Aurobindo Pharma Limited